All Practice Exams

118+ Free ANCC PMHNP Practice Questions

Prepare for the ANCC Psychiatric-Mental Health Nurse Practitioner (Across the Lifespan) Certification (PMHNP-BC) exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
82% first-time in 2025 (8,840 of 10,743) Pass Rate
118+ Questions
100% Free
2026 Statistics

Key Facts: ANCC PMHNP Exam

175

Total Questions

ANCC PMHNP page

3.5h

Exam Time

ANCC PMHNP page

82%

First-Time Pass Rate (2025)

ANCC 2025 Certification Data

27%

Advanced Practice Skills

ANCC PMHNP outline (2025-09-09)

23.1%

US Adults with Any Mental Illness

NIMH 2022

59.3M

Adults with Any Mental Illness

NIMH 2022

ANCC lists PMHNP-BC as a 175-question exam with 150 scored and 25 unscored pretest items, administered over 3.5 hours. The current outline contains 33 Scientific Foundation, 41 Advanced Practice Skills, 33 Diagnosis and Treatment, 17 Psychotherapy and Related Theories, and 26 Ethics, Legal Principles, and Cultural Care scored items. ANCC's 2025 data reports an 82% first-time pass rate: 8,840 of 10,743 candidates.

Sample ANCC PMHNP Practice Questions

Try these sample questions to test your ANCC PMHNP exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 118+ question experience with AI tutoring.

1A patient with schizophrenia is started on a high-potency D2 antagonist. Which dopamine pathway, when blocked, is most directly responsible for reducing positive symptoms such as hallucinations and delusions?
A.Nigrostriatal pathway
B.Mesolimbic pathway
C.Tuberoinfundibular pathway
D.Mesocortical pathway
Explanation: Hyperactivity of the mesolimbic dopamine pathway underlies positive psychotic symptoms; D2 blockade here reduces hallucinations and delusions.
2A PMHNP explains why SSRIs typically take 2 to 6 weeks to produce clinical antidepressant benefit despite blocking serotonin reuptake within hours. Which mechanism best accounts for this delay?
A.Hepatic enzyme induction that gradually increases the dose
B.Downstream neuroadaptive changes including receptor downregulation and increased neuroplasticity
C.Slow accumulation of the drug to toxic serum levels
D.Delayed absorption of the medication from the gut
Explanation: Therapeutic benefit lags receptor occupancy because of gradual neuroadaptation: presynaptic autoreceptor desensitization, postsynaptic receptor changes, and increased BDNF-mediated neuroplasticity.
3Benzodiazepines exert their anxiolytic and sedative effects primarily by modulating which neurotransmitter system?
A.They increase glutamate at NMDA receptors
B.They positively modulate GABA-A receptors, enhancing chloride influx
C.They block dopamine D2 receptors
D.They inhibit acetylcholinesterase
Explanation: Benzodiazepines are positive allosteric modulators of the GABA-A receptor, increasing the frequency of chloride channel opening and producing CNS inhibition.
4A patient is prescribed venlafaxine. At low doses it acts primarily on serotonin, but at higher doses it also increases norepinephrine. This medication is best classified as which of the following?
A.Selective serotonin reuptake inhibitor (SSRI)
B.Serotonin-norepinephrine reuptake inhibitor (SNRI)
C.Monoamine oxidase inhibitor (MAOI)
D.Norepinephrine-dopamine reuptake inhibitor (NDRI)
Explanation: Venlafaxine is an SNRI; its noradrenergic effects become prominent at higher doses, which is why blood pressure should be monitored.
5Which neurotransmitter is most strongly implicated in the reward and reinforcement circuitry that drives substance-use disorders?
A.Acetylcholine
B.Dopamine
C.Histamine
D.Glycine
Explanation: Dopamine release in the mesolimbic reward pathway (nucleus accumbens) mediates the reinforcing effects of substances of abuse.
6A trauma-exposed patient presents with hyperarousal and exaggerated startle. Dysregulation of which neuroendocrine system is most central to the chronic stress response in PTSD?
A.The hypothalamic-pituitary-thyroid axis
B.The hypothalamic-pituitary-adrenal (HPA) axis
C.The renin-angiotensin-aldosterone system
D.The hypothalamic-pituitary-gonadal axis
Explanation: The HPA axis governs the cortisol stress response; its dysregulation is a core neurobiologic feature of chronic stress and PTSD.
7Most antipsychotic medications share which core pharmacologic action that accounts for their antipsychotic efficacy?
A.Serotonin reuptake inhibition
B.Dopamine D2 receptor antagonism (or partial agonism)
C.GABA-A potentiation
D.Sodium channel blockade
Explanation: All approved antipsychotics share dopamine D2 receptor blockade or partial agonism; second-generation agents add 5-HT2A antagonism.
8A medication is metabolized by CYP2D6. A patient who is a poor metabolizer at this enzyme would be expected to have which response to a standard dose of an active CYP2D6 substrate?
A.Subtherapeutic drug levels and lack of effect
B.Higher drug levels and increased risk of dose-related side effects
C.No change because metabolism is unaffected
D.Accelerated clearance requiring a higher dose
Explanation: Poor CYP2D6 metabolizers clear substrate drugs slowly, leading to higher plasma concentrations and greater risk of dose-dependent adverse effects.
9Codeine and tramadol are prodrugs activated by CYP2D6. A CYP2D6 ultrarapid metabolizer taking codeine is at increased risk of which outcome?
A.No analgesia and complete lack of effect
B.Excess conversion to morphine with risk of opioid toxicity
C.Hepatotoxicity from accumulated codeine
D.Serotonin syndrome from blocked metabolism
Explanation: Ultrarapid metabolizers convert codeine to morphine rapidly and extensively, increasing the risk of opioid toxicity and respiratory depression.
10Which statement best reflects the current scientific understanding of pharmacogenomic testing in psychiatry?
A.A genotype report can independently select the single best antidepressant
B.Pharmacogenomic data can inform dosing and drug selection but does not replace clinical judgment
C.Pharmacogenomic testing can diagnose major depressive disorder
D.A favorable genotype eliminates the need to monitor for adverse effects
Explanation: Pharmacogenomic results are adjunctive: they may flag metabolizer status or drug interactions but must be integrated with the full clinical picture, not used alone.

About the ANCC PMHNP Exam

The ANCC PMHNP-BC exam validates advanced psychiatric-mental health NP competency across lifespan psychiatric assessment, diagnosis, treatment, psychotherapy, and ethical/legal care delivery.

Assessment

175 questions in 3.5 hours: 150 scored and 25 unscored pretest questions. Scored-item distribution is Scientific Foundation 33, Advanced Practice Skills 41, Diagnosis and Treatment 33, Psychotherapy and Related Theories 17, and Ethics, Legal Principles, and Cultural Care 26.

Time Limit

3 hours 30 minutes

Passing Score

Pass/Fail (ANCC scaled score)

Exam Fee

$220-$395, depending on eligible membership discount (ANCC)

ANCC PMHNP Exam Content Outline

22%

Scientific Foundation

Neurobiology, psychopathology concepts, and evidence integration for psychiatric-mental health care

27%

Advanced Practice Skills

Interviewing, mental status examination, risk formulation, and therapeutic alliance development

22%

Diagnosis and Treatment

DSM-5-TR reasoning, psychopharmacology planning, and integrated treatment decision-making

11%

Psychotherapy and Related Theories

Psychotherapeutic modalities, indications, and referral/co-management strategy

17%

Ethics, Legal Principles, and Cultural Care

Ethics, legal principles, cultural care, confidentiality, informed consent, duty to protect, scope, documentation, and equity

How to Pass the ANCC PMHNP Exam

What You Need to Know

  • Passing score: Pass/Fail (ANCC scaled score)
  • Assessment: 175 questions in 3.5 hours: 150 scored and 25 unscored pretest questions. Scored-item distribution is Scientific Foundation 33, Advanced Practice Skills 41, Diagnosis and Treatment 33, Psychotherapy and Related Theories 17, and Ethics, Legal Principles, and Cultural Care 26.
  • Time limit: 3 hours 30 minutes
  • Exam fee: $220-$395, depending on eligible membership discount

Keys to Passing

  • Work through all 118 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

ANCC PMHNP Study Tips from Top Performers

1Start each vignette with safety: suicidality, homicidality, psychosis severity, intoxication/withdrawal, and level-of-care needs
2Use DSM-5-TR criteria actively, but anchor diagnosis in longitudinal course and functional impairment
3Map every medication decision to monitoring: baseline labs, metabolic effects, EPS risk, and adherence barriers
4Link psychotherapy modality to presenting problem and patient readiness instead of defaulting to one approach
5Document legal and ethical reasoning explicitly for minors, involuntary treatment, and confidentiality exceptions

Frequently Asked Questions

How many questions are on the ANCC PMHNP exam?

ANCC lists 175 total questions with 150 scored and 25 unscored pretest items, administered over 3 hours and 30 minutes.

What is the ANCC PMHNP pass rate?

ANCC's 2025 Certification Data reports an 82% first-time pass rate for PMHNP-BC: 8,840 of 10,743 first-time candidates passed.

What are the PMHNP-BC content weights?

The current ANCC outline contains 33 Scientific Foundation items (22%), 41 Advanced Practice Skills (27%), 33 Diagnosis and Treatment (22%), 17 Psychotherapy and Related Theories (11%), and 26 Ethics, Legal Principles, and Cultural Care (17%) among 150 scored items; displayed percentages are rounded.

How much does ANCC PMHNP certification cost?

ANCC currently lists $220 for APNA members, $290 for AANP student members, $295 for ANA members, $340 for AANP, ISPN, or GAPNA members, and $395 for nonmembers. These initial-certification prices include a $140 nonrefundable administrative fee; verify the live ANCC page before applying.

How should I study for PMHNP board scenarios?

Practice integrated cases that force sequencing: safety triage, differential diagnosis, medication strategy, psychotherapy choice, and legal/ethical documentation decisions.

Why is PMHNP demand high?

NIMH estimates 23.1% of U.S. adults experienced any mental illness in 2022. Combined with rapid nurse practitioner workforce growth projected by BLS, psychiatric NP roles remain a high-demand pathway.